Chromsystems Recalls MassChrom Amino Acid Analysis Plasma Control Level II
Chromsystems Instruments & Chemicals GmbH is voluntarily recalling 363 vials of MassChrom Amino Acid Analysis Plasma Control Level II due to a Class II device defect.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product may cause temporary or medically reversible adverse health consequences. The source text does not report any specific injuries, illnesses, or deaths, and the reason for the recall is not explicitly detailed as a high-risk pathogen or structural defect, placing it in the Moderate category per the rubric.
Plain-English summary
Chromsystems Instruments & Chemicals GmbH has voluntarily recalled 363 vials of MassChrom Amino Acid Analysis Plasma Control Level II, Order No. 0472, Lot No. 2019. The recall was initiated on November 2, 2020, and is classified as Class II by the U.S. Food and Drug Administration. The specific reason for the recall is not detailed in the provided source text.
The affected product is intended for amino acid metabolic screening, confirmation of tentative diagnoses, and monitoring of treatment in individuals with metabolic disorders. The recall covers worldwide distribution, including the United States (specifically California and New York) and numerous international locations such as Australia, Belgium, Brazil, Germany, and Canada.
The recall was terminated on December 20, 2021. Consumers and healthcare facilities should check their inventory for the specific order and lot numbers listed above and stop using the product if it matches the recalled description.
The recalled product
- Product
- MassChrom Amino Acid Analysis Plasma Control Level II, Order No. 0472 - Product Usage: The kit is intended for amino acid metabolic screening, confirmation of a tentative diagnosis, and monitoring of treatment in individuals diagnosed with a metabolic disorder.
- Manufacturer
- Chromsystems Instruments & Chemicals GmbH
- Hazard
- Affected units
- 363
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Order No. 0472
- Lot No. 2019 (expiration 05/01/2022)
Distribution
Part of a larger recall action
This product is one of 4 recalled by Chromsystems Instruments & Chemicals GmbH under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Chromsystems Instruments & Chemicals GmbH
See all →- HighLaboratory Control Material Recalled for Insufficient Glycine Concentration
FDA (Devices) · 2022-07-13
- HighMedical Laboratory Control Material Recalled for Insufficient Glycine Concentration
FDA (Devices) · 2022-07-13
- HighChromsystems Recalls MassChrom Amino Acid Analysis Plasma Control Level III
FDA (Devices) · 2020-12-16
- ModerateChromsystems 3PLUS1 Multilevel Plasma Calibrator Set Recalled for Stability Issues
FDA (Devices) · 2020-12-16
- HighChromsystems MassChrom Amino Acid Analysis Plasma Control Level I Recalled
FDA (Devices) · 2020-12-16
Same hazard · device defect
See all →- HighBoston Scientific ENROUTE Transcarotid Neuroprotection System Recall for Tip Separation
FDA (Devices) · 2026-08-26
- HighMicrovention Recalls Bobby Balloon Guide Catheters Due to Pinhole Defects
FDA (Devices) · 2026-08-19
- SevereMedtronic Perfusion Systems Recalls EOPA Elongated One-Piece Arterial Cannula Model 77722
FDA (Devices) · 2026-08-05
- SevereABIOMED Impella CP Introducer Kit 14 Fr potentially defective sheath
FDA (Devices) · 2026-07-22
- SevereAbiomed Impella CP Smart Assist Set Heart Pump Introducer Sheath Leakage
FDA (Devices) · 2026-07-22